Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PLX · NYSE · Biological Products, (No Diagnostic Substances)
$2.90−0.16 (−5.23%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Protalix Biotherapeutics (PLX) · oqro.io/stocks/PLX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Oct 14, 2026 · Filed Oct 15, 2026
HOLD Alapkezelo Zrt. now owns 5.2% of PLX as a passive investorSourceInsider trade · Traded Dec 19, 2025 · Filed Dec 23, 2025
CEO purchased ~$101K of PLX shares in the open marketSourceInsider trade · Traded Nov 18, 2025 · Filed Nov 19, 2025
Director sold ~$314 of PLX shares in the open marketSourceInsider trade · Traded Jun 10, 2025 · Filed Aug 12, 2025
Director purchased ~$206K of PLX shares in the open marketSource